Published on in CHOP News
Globally, the microbiome is increasingly recognized as a primary determinant of human health and disease. With the support of a National Institutes of Health grant “Evaluation of the Gut-Kidney Axis in Kidney Stone Disease,” Greg Tasian, MD, MSc, MSCE, an attending pediatric urologist and world-renowned pediatric kidney stone expert at CHOP’s Pediatric Kidney Stone Center, is building upon previous research that looked into how the risk of kidney stones is influenced by changes in the gut microbiome — the community of organisms that inhabit our intestinal track. Learn more on Cornerstone, here.
Contact: Kaila Conti, The Children’s Hospital of Philadelphia, 267-426-6054 or email@example.com